<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, many of these formulations do not use the technology involved in any previously licensed vaccines (
 <xref rid="B37" ref-type="bibr">37</xref>). CEPI (Coalition for Epidemic Preparedness Innovation) estimated the development of Phase I clinical trials of 8 vaccines, Phase 2 and 3 trials for up to 6 vaccines and progression to regulatory approval and production of up to 3 candidates (
 <xref rid="B38" ref-type="bibr">38</xref>).
</p>
